Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Subscribe To Our Newsletter
Board Approves Three New Round 7 Proposals Following Successful Appeals
GFO Issue 85

Board Approves Three New Round 7 Proposals Following Successful Appeals

Author:

Board Approves Three New Round 7 Proposals Following Successful Appeals

Article Type:
News

Article Number: 4

ABSTRACT The Global Fund Board has approved three Round 7 proposals whose original rejection had been appealed by the applicants. The newly approved proposals are from Azerbaijan, Cambodia and Zambia.

The Global Fund Board has approved three of the seven Round 7 proposals whose original rejection had been appealed by the applicants. The newly approved proposals are a malaria proposal from Azerbaijan that will cost $2.5 million over the first two years, a TB proposal from Cambodia that will cost $8.7 million, and a TB proposal from Zambia that will cost $4.1 million. The approvals are subject to a number of requests for clarification being successfully responded to in a timely manner.

To be eligible for appeal, a proposal has to be have been turned down for funding in two consecutive rounds. Thirty proposals met this criterion in Round 7, but appeals were only filed for seven of these. The unsuccessful appeals were from Cameroon (two proposals, one for malaria and one for TB), Colombia (HIV/AIDS), and Sudan Northern Sector (HIV/AIDS).

The appeals were reviewed by an Independent Appeal Panel, comprised of two members of the TRP, together with an expert designated by Roll Back Malaria, an expert designated by the Stop TB Partnership, and an expert designated by UNAIDS, all of whom served in their personal capacities. The two TRP members had not been primary or secondary reviewers of the proposals under appeal.

With respect to the successful appeal from Azerbaijan, the Independent Appeal Panel found that the TRP had made a significant error in understanding the epidemiological data supplied by the applicant.

With respect to the successful appeal from Cambodia, the panel found that the TRP had erred in concluding that the weaknesses identified were sufficient to cause the proposal not to be approved. The Appeal Panel deemed that the applicant had already provided sufficient information in its original proposal and had addressed the comments raised by the TRP regarding the Round 6 proposal adequately.

With respect to the successful appeal from Zambia, the panel found that the TRP had erred in concluding that the budget and workplan were insufficiently detailed. The presentation of the budget was not in the format that the TRP had expected; but the underlying data were adequate.

As a general comment, the panel recommended that in future, the TRP separate weakness into two categories: those that the TRP considers to be ‘major weaknesses’, and those that are ‘minor weaknesses’ where a proposal could still be recommended for funding unless on balance there are too many of them.

Leave a reply

  • Anonymous comments (0)
  • Facebook Comments

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading